EMA Recommends Extensions of Indications for Cabozantinib

2018-03-27 12:41:00

New indication concerns treatment-naive adults with intermediate or poor risk advanced RCC

Source

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply